Abiopharma

🔍 Sleeper Nathan K (Director)

Company: COLUMBUS MCKINNON CORP (CMCO)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 7,590 shares of Common Stock at $19.105 per share (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,590.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated effective June 4, 2024, and further amended effective August 14, 2026.
• F2: The reporting person holds the 7,590 shares of common stock for the benefit of, and is obligated to transfer such shares of common stock to, CD&R XII Keystone Holdings, L.P. or an affiliate thereof ("CD&R"), and the reporting person therefore disclaims beneficial ownership of the reported securities.